These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Douma CE, Hiralall JK, de Waart DR, Struijk DG, Krediet RT. Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412 [Abstract] [Full Text] [Related]
3. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE, de Waart DR, Struijk DG, Krediet RT. Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [Abstract] [Full Text] [Related]
4. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? Douma CE, de Waart DR, Struijk DG, Krediet RT. J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705 [Abstract] [Full Text] [Related]
5. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD. Douma CE, de Waart DR, Zemel D, Struijk DG, Krediet RT. Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278 [Abstract] [Full Text] [Related]
6. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits. Douma CE, Zweers MM, de Waart DR, van der Wardt AB, Krediet RT, Struijk DG. Perit Dial Int; 1999 Apr; 19 Suppl 2():S358-64. PubMed ID: 10406547 [Abstract] [Full Text] [Related]
7. Similarities and differences between the effects of amino acids and nitroprusside on peritoneal permeability during CAPD. Douma CE, Imholz AL, Struijk DG, Krediet RT. Blood Purif; 1998 Apr; 16(2):57-65. PubMed ID: 9572398 [Abstract] [Full Text] [Related]
8. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis. Smit W, de Waart DR, Struijk DG, Krediet RT. Perit Dial Int; 2000 Apr; 20(5):557-65. PubMed ID: 11117247 [Abstract] [Full Text] [Related]
9. Peritoneal transport characteristics with glucose polymer based dialysate. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, Krediet RT. Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974 [Abstract] [Full Text] [Related]
10. The standard peritoneal permeability analysis in the rabbit: a longitudinal model for peritoneal dialysis. Zweers MM, Douma CE, de Waart DR, van der Wardt AB, Ho-dac-Pannekeet MM, Krediet RT, Struijk DG. Perit Dial Int; 1999 Sep; 19(1):56-64. PubMed ID: 10201342 [Abstract] [Full Text] [Related]
11. Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients. Kanjanabuch T, Eiam-Ong S. J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S129-37. PubMed ID: 17044464 [Abstract] [Full Text] [Related]
12. [Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients]. Tan XY, Liu FY, Duan SB. Hunan Yi Ke Da Xue Xue Bao; 2000 Aug 28; 25(4):357-60. PubMed ID: 12206001 [Abstract] [Full Text] [Related]
13. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Kidney Int; 1993 Jun 28; 43(6):1339-46. PubMed ID: 8315948 [Abstract] [Full Text] [Related]
14. Nitrate in stable CAPD patients and during peritonitis. Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, Krediet RT. Adv Perit Dial; 1995 Jun 28; 11():36-40. PubMed ID: 8534733 [Abstract] [Full Text] [Related]
15. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations. Plum J, Fusshöller A, Schoenicke G, Busch T, Erren C, Fieseler C, Kirchgessner J, Passlick-Deetjen J, Grabensee B. Nephrol Dial Transplant; 1997 Aug 28; 12(8):1652-60. PubMed ID: 9269644 [Abstract] [Full Text] [Related]
16. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT. J Lab Clin Med; 1993 Dec 28; 122(6):686-96. PubMed ID: 8245688 [Abstract] [Full Text] [Related]
17. Growth factors VEGF and TGF-beta1 in peritoneal dialysis. Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT. J Lab Clin Med; 1999 Aug 28; 134(2):124-32. PubMed ID: 10444025 [Abstract] [Full Text] [Related]
18. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function. Smit W, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, Krediet RT. Perit Dial Int; 2000 Aug 28; 20(6):734-41. PubMed ID: 11216568 [Abstract] [Full Text] [Related]
19. Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis. Ho-dac-Pannekeet MM, Koopmans JG, Struijk DG, Krediet RT. Adv Perit Dial; 1997 Aug 28; 13():72-6. PubMed ID: 9360654 [Abstract] [Full Text] [Related]
20. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, de Waart R, Hiralall J, Krediet RT. Kidney Int; 1995 Sep 28; 48(3):866-75. PubMed ID: 7474677 [Abstract] [Full Text] [Related] Page: [Next] [New Search]